Acadia Healthcare Raises FY2026 Financial Guidance
Acadia raised its full-year 2026 revenue, earnings and cash flow guidance and lowered its capital expenditure guidance after third-quarter revenue and Adjusted EBITDA growth.
Acadia Healthcare reported growth in its third-quarter revenue and Adjusted EBITDA, supported by bed expansion and improved free cash flow. Consequently, the company raised its full-year 2026 guidance for revenue, earnings, and cash flow. Additionally, the company lowered its capital expenditure guidance for the year.